The long 3′ UTR of PD-L1 harbors several potential miRNA binding sites, such as those for miR-34 and miR-200; therefore, relief of PD-L1 from miRNA-mediated inhibition might be one of the mechanisms responsible for its increased expression in cancers, although it was not investigated in this study. The gene discussed is CD274; the disease is cancer.